Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells

Bibliographic Details
Main Authors: S. Moreno, M. López Huertas, L. Jiménez Tormo, N. Madrid Elena, C. Gutierrez, M.J. Vivancos, L. Luna
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020302120